Given that subcutaneous insulin administration bypasses the hepatic filter, which physiologically halves its concentration, the adequate dosage of boluses at meals often can be addressed with a diet that limits postprandial hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.